Cargando…

The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis

BACKGROUND & AIMS: The fragile X mental retardation protein (FMRP) affects multiple steps of the mRNA metabolism during brain development and in different neoplastic processes. However, the contribution of FMRP in colon carcinogenesis has not been investigated. METHODS: FMR1 mRNA transcript and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Grazia, Antonio, Marafini, Irene, Pedini, Giorgia, Di Fusco, Davide, Laudisi, Federica, Dinallo, Vincenzo, Rosina, Eleonora, Stolfi, Carmine, Franzè, Eleonora, Sileri, Pierpaolo, Sica, Giuseppe, Monteleone, Giovanni, Bagni, Claudia, Monteleone, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806864/ https://www.ncbi.nlm.nih.gov/pubmed/33091622 http://dx.doi.org/10.1016/j.jcmgh.2020.10.009

Ejemplares similares

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals
por: Marafini, Irene, et al.
Publicado: (2019)

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
por: Di Grazia, Antonio, et al.
Publicado: (2020)

Progranulin sustains STAT3 hyper‐activation and oncogenic function in colorectal cancer cells
por: Laudisi, Federica, et al.
Publicado: (2019)

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue
por: Franzè, Eleonora, et al.
Publicado: (2017)

Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
por: Salvatori, Silvia, et al.
Publicado: (2023)

Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model
por: Dinallo, Vincenzo, et al.
Publicado: (2019)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease
por: Monteleone, Giovanni, et al.
Publicado: (2020)

Interleukin-34 Enhances the Tumor Promoting Function of Colorectal Cancer-Associated Fibroblasts
por: Franzè, Eleonora, et al.
Publicado: (2020)

Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease
por: Di Grazia, Antonio, et al.
Publicado: (2022)

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death
por: De Simone, Veronica, et al.
Publicado: (2017)

The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation
por: Laudisi, Federica, et al.
Publicado: (2018)

Macrophages produce and functionally respond to interleukin-34 in colon cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Impact of Food Additives on Gut Homeostasis
por: Laudisi, Federica, et al.
Publicado: (2019)

Smad7 as a positive regulator of intestinal inflammatory diseases
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Association Between Celiac Disease and Cancer
por: Marafini, Irene, et al.
Publicado: (2020)

Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis
por: De Simone, Veronica, et al.
Publicado: (2015)

Follistatin-like protein 1 sustains colon cancer cell growth and survival
por: Bevivino, Gerolamo, et al.
Publicado: (2018)

Corrigendum: An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa
por: Di Fusco, Davide, et al.
Publicado: (2023)

An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa
por: Di Fusco, Davide, et al.
Publicado: (2023)

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
por: Stolfi, Carmine, et al.
Publicado: (2011)

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
por: Stolfi, Carmine, et al.
Publicado: (2022)

Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier
por: Stolfi, Carmine, et al.
Publicado: (2023)

Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells
por: Maresca, Claudia, et al.
Publicado: (2022)

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
por: Troncone, Edoardo, et al.
Publicado: (2018)

Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
por: Troncone, Edoardo, et al.
Publicado: (2021)

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
por: Stolfi, Carmine, et al.
Publicado: (2020)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
por: Di Fusco, Davide, et al.
Publicado: (2019)

Interleukin-34 promotes tumorigenic signals for colon cancer cells
por: Franzè, Eleonora, et al.
Publicado: (2021)

Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
por: De Simone, V, et al.
Publicado: (2015)

Anthelmintic Drugs as Emerging Immune Modulators in Cancer
por: Stolfi, Carmine, et al.
Publicado: (2023)

A functional role for Smad7 in sustaining colon cancer cell growth and survival
por: Stolfi, C, et al.
Publicado: (2014)

The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
por: Stolfi, Carmine, et al.
Publicado: (2013)

Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
por: Monteleone, Giovanni, et al.
Publicado: (2022)

mTOR sustains inflammatory response in celiac disease
por: Sedda, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0lugse2nofp0flqb3843g0r4p5